Registry of Patients Referred for Heart Transplantation
POLKARD HF
National Polish Registry of Patients Referred for Heart Transplantation. POLKARD HF
1 other identifier
observational
999
1 country
5
Brief Summary
Main goal of the study is the risk stratification of patients with advanced heart failure referred for orthotopic heart transplantation (OHT) according to HFSS score, other risk factors and biological markers and verification of their prognostic value in Polish population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2003
Longer than P75 for all trials
5 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2003
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2007
CompletedFirst Submitted
Initial submission to the registry
May 29, 2008
CompletedFirst Posted
Study publicly available on registry
June 4, 2008
CompletedSeptember 15, 2009
September 1, 2009
4 years
May 29, 2008
September 14, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Death for all causes or urgent heart transplantation
prospective progressive 1 to 48 months
Secondary Outcomes (1)
Death without heart transplantation
prospective , progressive 1 to 48 months
Eligibility Criteria
Patients with advanced heart failure referred for orthotropic heart transplantation (OHT)
You may qualify if:
- men and women aged \>10 years with advanced heart failure
- referred as potential candidates for orthotropic heart transplantation
You may not qualify if:
- refusal to participate in the registry
- not enlisted for heart transplantation (since 2006)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (5)
Klinika Chirurgii Serca, Naczyń i Transplantologii, Szpital im.Jan Pawłą II
Krakow, 31202, Poland
Klinika Kardiochirurgii CSK MSWiA
Warsaw, 02-507, Poland
II Klinika Kardiochirurgii Instytutu Kardiologii
Warsaw, 04-628, Poland
Klinika Niewydolności Serca i Transplantologii Instytutu Kardiologii
Warsaw, 04-628, Poland
Śląskie Centrum Chorób Serca
Zabrze, 41-800, Poland
Related Publications (5)
Korewicki J., Browarek A., Zielinski T., Sobieszczanska-Małek M., Piotrowska M., Zembala M., Zakliczynski M., Rozentryt P., Baranska-Kosakowska A., Sadowski J., Przybyłowski P., Milaniak I., Garlicki M.: Prognosis of patients with advanced heart failure referred for heart transplantation data of POLKARD HF 2003-2005.[Rokowanie chorych z ciężką niewydolnością serca, wstępnie kwalifikowanych do przeszczepu serca - na podstawie danych ogólnopolskiego rejestru POLKARD 2003-2005.] Kardiochir. Torakochir. Pol., 2006(3): 308 - 322.
RESULTKorewicki J. Cardiac transplantation is still the method of choice in the treatment of patients with severe heart failure. Cardiol J. 2009;16(6):493-9.
PMID: 19950084DERIVEDZielinski T, Sobieszczanska-Malek M, Browarek A, Piotrowska M, Zakliczynski M, Przybylowski P, Roguski K, Sadowski J, Zembala M, Korewicki J; POLKARD HF investigators. The influence of the recipient's body weight on the probability to obtain a heart transplant-POLKARD HF registry. Transplant Proc. 2009 Oct;41(8):3166-70. doi: 10.1016/j.transproceed.2009.08.015.
PMID: 19857703DERIVEDZielinski T, Browarek A, Zembala M, Sadowski J, Zakliczynski M, Przybylowski P, Roguski K, Kosakowska AB, Korewicki J; POLKARD HF investigators. Risk stratification of patients with severe heart failure awaiting heart transplantation-prospective national registry POLKARD HF. Transplant Proc. 2009 Oct;41(8):3161-5. doi: 10.1016/j.transproceed.2009.09.049.
PMID: 19857702DERIVEDZielinski T, Kurjata P, Korewicki J; participants of POLKARD-HF. Prognosis in patients with severe heart failure referred for heart transplantation--POLKARD-HF 2003-2007. Int J Cardiol. 2010 Nov 19;145(2):242-244. doi: 10.1016/j.ijcard.2009.08.026. Epub 2009 Sep 15.
PMID: 19755203DERIVED
Biospecimen
whole blood
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marian Zembala, MD,PhD, Prof
Śląskie Centrum Chorób Serca,Klinika Kardiochirurgii,ul. Szpitalna 2, 41-800 Zabrze
- PRINCIPAL INVESTIGATOR
Jerzy Sadowski, MD,PhD, Prof
Collegium Medicum Uniwersytetu Jagiellońskiego,Klinika Chirurgii Serca Naczyń i Transplantologii,ul. Prądnicka 80, 31-202 Kraków
- PRINCIPAL INVESTIGATOR
Mirosław Garlicki, MD, PhD
Klinika Kardiochirurgii Centralnego Szpitala Klinicznego MSWiA, ul. Wołoska 137, 02-507 Warszawa
- STUDY DIRECTOR
Jerzy Korewicki, MD,PhD, Prof
Klinika Niewydolności Serca i Transplantologii, Instytut Kardiologii, 04-628 Warszawa ul.Alpejska 42
- PRINCIPAL INVESTIGATOR
Aldona Browarek, MD, PhD
Klinika Niewydolności Serca i Transplantologii, Instytut Kardiologii, 04-628 Warszawa ul.Alpejska 42
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 29, 2008
First Posted
June 4, 2008
Study Start
October 1, 2003
Primary Completion
October 1, 2007
Study Completion
October 1, 2007
Last Updated
September 15, 2009
Record last verified: 2009-09